Share Price and Basic Stock Data
Last Updated: February 24, 2025, 12:07 pm
PEG Ratio | 2.48 |
---|
Competitors of IEL Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
IEL Ltd | 84.8 Cr. | 6.35 | 8.71/3.36 | 107 | 0.13 | 0.00 % | 17.5 % | 23.6 % | 1.00 |
Evexia Lifecare Ltd | 505 Cr. | 2.69 | 4.40/1.94 | 134 | 1.80 | 0.00 % | 0.30 % | 1.26 % | 1.00 |
Diligent Industries Ltd | 43.6 Cr. | 1.83 | 6.29/1.74 | 15.2 | 0.83 | 0.00 % | 7.35 % | 12.0 % | 1.00 |
CIAN Agro Industries & Infrastructure Ltd | 1,139 Cr. | 407 | 540/36.1 | 218 | 31.9 | 0.00 % | 11.1 % | 5.85 % | 10.0 |
BCL Industries Ltd | 1,134 Cr. | 38.4 | 81.4/34.5 | 12.2 | 25.6 | 0.64 % | 15.7 % | 16.0 % | 1.00 |
Industry Average | 9,907.69 Cr | 114.87 | 52.05 | 28.27 | 0.21% | 11.32% | 10.26% | 4.33 |
Quarterly Result
Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 0.35 | 0.00 | 0.45 | 0.19 | 3.94 | 5.91 | 1.03 | 1.61 | 1.04 | 5.49 | 9.12 | 5.31 | 0.00 |
Expenses | 0.42 | 0.05 | 0.04 | 0.02 | 2.58 | 4.97 | 1.11 | 1.52 | 1.08 | 5.35 | 8.93 | 5.12 | 0.05 |
Operating Profit | -0.07 | -0.05 | 0.41 | 0.17 | 1.36 | 0.94 | -0.08 | 0.09 | -0.04 | 0.14 | 0.19 | 0.19 | -0.05 |
OPM % | -20.00% | 91.11% | 89.47% | 34.52% | 15.91% | -7.77% | 5.59% | -3.85% | 2.55% | 2.08% | 3.58% | ||
Other Income | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.22 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Profit before tax | 0.03 | -0.06 | 0.39 | 0.15 | 1.34 | 0.92 | -0.05 | 0.08 | -0.05 | 0.13 | 0.18 | 0.40 | 0.16 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -20.00% | 25.00% | 0.00% | 15.38% | 27.78% | 25.00% | 18.75% |
Net Profit | 0.03 | -0.06 | 0.39 | 0.15 | 1.34 | 0.92 | -0.04 | 0.06 | -0.05 | 0.11 | 0.14 | 0.31 | 0.13 |
EPS in Rs | 0.01 | -0.02 | 0.12 | 0.04 | 0.40 | 0.28 | -0.01 | 0.02 | -0.01 | 0.03 | 0.04 | 0.09 | 0.04 |
Last Updated: November 6, 2024, 6:31 pm
Profit & Loss - Annual Report
Last Updated: February 20, 2025, 2:22 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 2.91 | 1.48 | 0.02 | -0.06 | 0.00 | 1.26 | 2.12 | 3.87 | 0.96 | 0.64 | 10.19 | 17.11 | 14.83 |
Expenses | 2.87 | 2.11 | 2.15 | 0.29 | 0.32 | 1.42 | 2.22 | 3.98 | 1.11 | 0.82 | 8.64 | 16.88 | 14.23 |
Operating Profit | 0.04 | -0.63 | -2.13 | -0.35 | -0.32 | -0.16 | -0.10 | -0.11 | -0.15 | -0.18 | 1.55 | 0.23 | 0.60 |
OPM % | 1.37% | -42.57% | -10,650.00% | -12.70% | -4.72% | -2.84% | -15.62% | -28.12% | 15.21% | 1.34% | 4.05% | ||
Other Income | 0.22 | 0.03 | 0.17 | 0.05 | 0.20 | 0.20 | 0.32 | 0.22 | 0.38 | 0.59 | 0.87 | 0.15 | 0.46 |
Interest | 0.41 | 0.01 | 0.00 | 0.03 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.07 | 0.05 | 0.17 | 0.11 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.07 | 0.03 | 0.04 |
Profit before tax | -0.22 | -0.66 | -2.13 | -0.44 | -0.22 | -0.07 | 0.13 | 0.02 | 0.14 | 0.32 | 2.35 | 0.35 | 1.02 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.43% | 25.71% | |
Net Profit | -0.21 | -0.67 | -2.13 | -0.44 | -0.22 | -0.07 | 0.12 | 0.02 | 0.14 | 0.32 | 2.37 | 0.26 | 0.79 |
EPS in Rs | -0.02 | -0.05 | -0.16 | -0.03 | -0.02 | -0.01 | 0.01 | 0.00 | 0.01 | 0.02 | 0.18 | 0.02 | 0.06 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -219.05% | -217.91% | 79.34% | 50.00% | 68.18% | 271.43% | -83.33% | 600.00% | 128.57% | 640.62% | -89.03% |
Change in YoY Net Profit Growth (%) | 0.00% | 1.14% | 297.25% | -29.34% | 18.18% | 203.25% | -354.76% | 683.33% | -471.43% | 512.05% | -729.65% |
IEL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 28% |
5 Years: | 52% |
3 Years: | 161% |
TTM: | 62% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 92% |
3 Years: | 23% |
TTM: | 1029% |
Stock Price CAGR | |
---|---|
10 Years: | 20% |
5 Years: | 125% |
3 Years: | -2% |
1 Year: | -14% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 40% |
3 Years: | 65% |
Last Year: | 24% |
Last Updated: Unknown
Balance Sheet
Last Updated: February 12, 2025, 1:32 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 | 3.34 |
Reserves | 1.75 | 1.00 | -1.13 | -1.57 | -0.90 | -1.86 | -1.74 | -1.72 | -1.58 | -1.26 | -2.37 | -2.11 | -1.67 |
Borrowings | 1.51 | 0.96 | 0.91 | 1.00 | 0.01 | 0.91 | 0.91 | 0.90 | 0.91 | 0.91 | 0.90 | 0.90 | 0.90 |
Other Liabilities | 0.61 | 2.00 | 1.31 | 1.53 | 1.76 | 3.90 | 1.55 | 2.13 | 1.37 | 1.65 | 1.67 | 1.63 | 0.55 |
Total Liabilities | 7.21 | 7.30 | 4.43 | 4.30 | 4.21 | 6.29 | 4.06 | 4.65 | 4.04 | 4.64 | 3.54 | 3.76 | 3.12 |
Fixed Assets | 4.50 | 4.38 | 4.21 | 4.09 | 3.99 | 3.89 | 3.80 | 3.71 | 3.62 | 3.53 | 0.20 | 0.17 | 0.16 |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.27 |
Other Assets | 2.71 | 2.92 | 0.22 | 0.21 | 0.22 | 2.40 | 0.26 | 0.94 | 0.42 | 1.11 | 3.34 | 3.59 | 2.69 |
Total Assets | 7.21 | 7.30 | 4.43 | 4.30 | 4.21 | 6.29 | 4.06 | 4.65 | 4.04 | 4.64 | 3.54 | 3.76 | 3.12 |
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -1.47 | -1.59 | -3.04 | -1.35 | -0.33 | -1.07 | -1.01 | -1.01 | -1.06 | -1.09 | 0.65 | -0.67 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 90.31 | 167.70 | 0.00 | 0.00 | 353.41 | 6.89 | 20.75 | 114.06 | 285.16 | 82.03 | 35.41 | |
Inventory Days | 63.64 | 85.59 | 0.00 | 300.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.52 | ||
Days Payable | 43.05 | 402.76 | 694.47 | 34.34 | ||||||||
Cash Conversion Cycle | 110.90 | -149.47 | 0.00 | 0.00 | -40.66 | 6.89 | 20.75 | 114.06 | 285.16 | 82.03 | 23.59 | |
Working Capital Days | 115.40 | -187.43 | -21,170.00 | -8,942.50 | 8.69 | -13.77 | -72.62 | 15.21 | 182.50 | 26.51 | 32.64 | |
ROCE % | 1.07% | -11.26% | -51.31% | -13.92% | -8.43% | -2.48% | 0.82% | 0.80% | 5.39% | 11.31% | 96.30% | 17.50% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 0.08 | 7.09 | 0.96 | 0.41 | 0.07 |
Diluted EPS (Rs.) | 0.08 | 7.09 | 0.96 | 0.41 | 0.07 |
Cash EPS (Rs.) | 0.08 | 7.29 | 1.22 | 0.67 | 0.33 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 0.36 | 2.90 | -4.19 | -5.15 | 4.60 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 0.36 | 2.90 | 6.22 | 5.26 | 4.85 |
Revenue From Operations / Share (Rs.) | 5.13 | 30.53 | 1.91 | 2.87 | 11.60 |
PBDIT / Share (Rs.) | 0.11 | 7.25 | 1.22 | 0.68 | 0.34 |
PBIT / Share (Rs.) | 0.10 | 7.05 | 0.96 | 0.41 | 0.07 |
PBT / Share (Rs.) | 0.10 | 7.06 | 0.95 | 0.41 | 0.06 |
Net Profit / Share (Rs.) | 0.07 | 7.09 | 0.95 | 0.41 | 0.06 |
PBDIT Margin (%) | 2.22 | 23.74 | 63.86 | 23.72 | 2.99 |
PBIT Margin (%) | 2.02 | 23.09 | 50.45 | 14.54 | 0.66 |
PBT Margin (%) | 2.02 | 23.13 | 50.07 | 14.29 | 0.57 |
Net Profit Margin (%) | 1.50 | 23.22 | 50.07 | 14.29 | 0.57 |
Return on Networth / Equity (%) | 20.98 | 244.77 | -22.85 | -7.97 | 1.46 |
Return on Capital Employeed (%) | 16.33 | 126.07 | 7.95 | 3.73 | 0.71 |
Return On Assets (%) | 6.83 | 66.91 | 6.88 | 3.39 | 0.48 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Total Debt / Equity (X) | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
Asset Turnover Ratio (%) | 4.69 | 2.49 | 0.14 | 0.22 | 0.88 |
Current Ratio (X) | 2.18 | 1.99 | 1.88 | 1.33 | 0.85 |
Quick Ratio (X) | 1.56 | 1.99 | 1.88 | 1.33 | 0.85 |
Interest Coverage Ratio (X) | 695.97 | 897.67 | 169.74 | 95.84 | 34.96 |
Interest Coverage Ratio (Post Tax) (X) | 471.35 | 876.31 | 134.10 | 58.75 | 7.77 |
Enterprise Value (Cr.) | 27.89 | 31.04 | 20.33 | 4.21 | 0.74 |
EV / Net Operating Revenue (X) | 1.63 | 3.05 | 31.83 | 4.39 | 0.19 |
EV / EBITDA (X) | 73.40 | 12.82 | 49.84 | 18.50 | 6.43 |
MarketCap / Net Operating Revenue (X) | 1.60 | 3.05 | 30.72 | 3.50 | 0.11 |
Price / BV (X) | 22.40 | 32.12 | -14.02 | -1.95 | 0.29 |
Price / Net Operating Revenue (X) | 1.60 | 3.05 | 30.74 | 3.50 | 0.11 |
EarningsYield | 0.01 | 0.07 | 0.01 | 0.04 | 0.04 |
After reviewing the key financial ratios for IEL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 23) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 7.09 (Mar 23) to 0.08, marking a decrease of 7.01.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 7.09 (Mar 23) to 0.08, marking a decrease of 7.01.
- For Cash EPS (Rs.), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 3. It has decreased from 7.29 (Mar 23) to 0.08, marking a decrease of 7.21.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 0.36. It has decreased from 2.90 (Mar 23) to 0.36, marking a decrease of 2.54.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 0.36. It has decreased from 2.90 (Mar 23) to 0.36, marking a decrease of 2.54.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 5.13. It has decreased from 30.53 (Mar 23) to 5.13, marking a decrease of 25.40.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 2. It has decreased from 7.25 (Mar 23) to 0.11, marking a decrease of 7.14.
- For PBIT / Share (Rs.), as of Mar 24, the value is 0.10. This value is within the healthy range. It has decreased from 7.05 (Mar 23) to 0.10, marking a decrease of 6.95.
- For PBT / Share (Rs.), as of Mar 24, the value is 0.10. This value is within the healthy range. It has decreased from 7.06 (Mar 23) to 0.10, marking a decrease of 6.96.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 2. It has decreased from 7.09 (Mar 23) to 0.07, marking a decrease of 7.02.
- For PBDIT Margin (%), as of Mar 24, the value is 2.22. This value is below the healthy minimum of 10. It has decreased from 23.74 (Mar 23) to 2.22, marking a decrease of 21.52.
- For PBIT Margin (%), as of Mar 24, the value is 2.02. This value is below the healthy minimum of 10. It has decreased from 23.09 (Mar 23) to 2.02, marking a decrease of 21.07.
- For PBT Margin (%), as of Mar 24, the value is 2.02. This value is below the healthy minimum of 10. It has decreased from 23.13 (Mar 23) to 2.02, marking a decrease of 21.11.
- For Net Profit Margin (%), as of Mar 24, the value is 1.50. This value is below the healthy minimum of 5. It has decreased from 23.22 (Mar 23) to 1.50, marking a decrease of 21.72.
- For Return on Networth / Equity (%), as of Mar 24, the value is 20.98. This value is within the healthy range. It has decreased from 244.77 (Mar 23) to 20.98, marking a decrease of 223.79.
- For Return on Capital Employeed (%), as of Mar 24, the value is 16.33. This value is within the healthy range. It has decreased from 126.07 (Mar 23) to 16.33, marking a decrease of 109.74.
- For Return On Assets (%), as of Mar 24, the value is 6.83. This value is within the healthy range. It has decreased from 66.91 (Mar 23) to 6.83, marking a decrease of 60.08.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 4.69. It has increased from 2.49 (Mar 23) to 4.69, marking an increase of 2.20.
- For Current Ratio (X), as of Mar 24, the value is 2.18. This value is within the healthy range. It has increased from 1.99 (Mar 23) to 2.18, marking an increase of 0.19.
- For Quick Ratio (X), as of Mar 24, the value is 1.56. This value is within the healthy range. It has decreased from 1.99 (Mar 23) to 1.56, marking a decrease of 0.43.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 695.97. This value is within the healthy range. It has decreased from 897.67 (Mar 23) to 695.97, marking a decrease of 201.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 471.35. This value is within the healthy range. It has decreased from 876.31 (Mar 23) to 471.35, marking a decrease of 404.96.
- For Enterprise Value (Cr.), as of Mar 24, the value is 27.89. It has decreased from 31.04 (Mar 23) to 27.89, marking a decrease of 3.15.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.63. This value is within the healthy range. It has decreased from 3.05 (Mar 23) to 1.63, marking a decrease of 1.42.
- For EV / EBITDA (X), as of Mar 24, the value is 73.40. This value exceeds the healthy maximum of 15. It has increased from 12.82 (Mar 23) to 73.40, marking an increase of 60.58.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has decreased from 3.05 (Mar 23) to 1.60, marking a decrease of 1.45.
- For Price / BV (X), as of Mar 24, the value is 22.40. This value exceeds the healthy maximum of 3. It has decreased from 32.12 (Mar 23) to 22.40, marking a decrease of 9.72.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has decreased from 3.05 (Mar 23) to 1.60, marking a decrease of 1.45.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 23) to 0.01, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in IEL Ltd:
- Net Profit Margin: 1.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.33% (Industry Average ROCE: 11.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.98% (Industry Average ROE: 10.26%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 471.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 107 (Industry average Stock P/E: 52.05)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.5%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Edible Oils & Solvent Extraction | Shed No 15. Shyam Hari Industrial Estate. Phase 4, GIDC, Vatva, Ahmedabad Gujarat 382445 | iel@nanavatigroup.com http://www.nanavatigroup.com |
Management | |
---|---|
Name | Position Held |
Mr. Ronit Champaklal Shah | Chairman & Director |
Mr. Arpit Singh | Non Exe.Non Ind.Director |
Ms. Ajay Bholanath Gupta | Managing Director |
Mr. Parshva Satishkumar Shah | Independent Director |
Ms. Juhi Sajwani | Independent Director |
Ms. Avani Shah | Independent Director |
FAQ
What is the latest intrinsic value of IEL Ltd?
Let's break down IEL Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 24 February 2025:
- Calculated Fair Value: ₹2.68
- Current Market Price: ₹6.35
- Variance: 57.80% lower
This suggests IEL Ltd is currently overvalued by 57.80%. For context:
- Market Cap: 84.8 Cr.
- 52-Week Range: 8.71/3.36
- Reserves (Sep 2024): ₹-1.67 Cr
- Liabilities: 3.12 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of IEL Ltd?
The Market Cap of IEL Ltd is 84.8 Cr..
What is the current Stock Price of IEL Ltd as on 24 February 2025?
The current stock price of IEL Ltd as on 24 February 2025 is ₹6.35.
What is the High / Low of IEL Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of IEL Ltd stocks is 8.71/3.36.
What is the Stock P/E of IEL Ltd?
The Stock P/E of IEL Ltd is 107.
What is the Book Value of IEL Ltd?
The Book Value of IEL Ltd is 0.13.
What is the Dividend Yield of IEL Ltd?
The Dividend Yield of IEL Ltd is 0.00 %.
What is the ROCE of IEL Ltd?
The ROCE of IEL Ltd is 17.5 %.
What is the ROE of IEL Ltd?
The ROE of IEL Ltd is 23.6 %.
What is the Face Value of IEL Ltd?
The Face Value of IEL Ltd is 1.00.